Disc Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	360.38	194.61	88.04	4.5	3.31
Cash & Cash Equivalents	360.38	194.61	88.04	4.5	3.31
Cash Growth	85.18%	121.06%	1855.05%	36.08%	-
Other Current Assets	5.28	3.88	2.45	0.56	1.92
Total Current Assets	365.66	198.49	90.48	5.07	5.23
Property, Plant & Equipment	2.1	1.6	1.75	0.29	0.59
Long-Term Investments	0	0	0	0.32	0
Other Long-Term Assets	0.23	0.12	0.18	2.64	0.33
Total Long-Term Assets	2.33	1.71	1.93	3.25	0.92
Total Assets	368	200.21	92.41	8.32	6.14
Accounts Payable	12.63	16.16	2.56	2.38	3.8
Current Debt	0.67	0.31	0.32	16.69	2.5
Other Current Liabilities	8.15	6.11	10.55	5.81	2.69
Total Current Liabilities	21.44	22.58	13.42	24.88	8.99
Long-Term Debt	1.44	1.03	1.33	4.95	7.41
Other Long-Term Liabilities	0	0	0	0.35	0.18
Total Long-Term Liabilities	1.44	1.03	1.33	5.3	7.59
Total Liabilities	22.88	23.61	14.76	30.18	16.58
Total Debt	2.1	1.33	1.65	21.64	9.91
Debt Growth	57.50%	-19.30%	-92.36%	118.34%	-
Retained Earnings	-188.65	-112.22	-65.39	-112.82	-71.98
Shareholders' Equity	345.12	176.6	-64.2	-21.86	-70.8
Net Cash / Debt	358.28	193.28	86.38	-17.14	-6.6
Net Cash / Debt Growth	85.37%	123.74%	-	-	-
Net Cash Per Share	16.05	185.93	98.34	-11.34	-12.77
Working Capital	344.22	175.91	77.06	-19.81	-3.76
Book Value Per Share	15.46	169.89	-73.09	-14.46	-136.90

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).